No Data
Express News | Shandong Bucang Pharmaceuticals: Wholly-owned subsidiary Tonghua Guhong received the pharmaceutical GMP compliance inspection results
Buchang Pharmaceuticals to Invest 11 Million Yuan to Set Up Six Subsidiaries
Shandong Buchang Pharmaceuticals (603858.SH): plans to invest a total of 11.13 million yuan to establish six controlled subsidiaries.
Gelonghui reported on November 22 that shandong buchang pharmaceuticals (603858.SH) announced that in order to improve its strategic development layout and gain a competitive advantage in the market based on segmented management, it intends to invest a total of 11.13 million yuan to establish six holding subsidiaries, namely shandong buchang chuangfang pharmaceuticals Co., Ltd., buchang lianchuang trading Co., Ltd., buchang dingxin trading Co., Ltd., buchang mailitong trading Co., Ltd., buchang zongfushou pharmaceuticals Co., Ltd., and shandong buchang ruifeng technology Co., Ltd. (subject to industrial and commercial registration). In order to promote a win-win situation for the company and all parties involved.
Shandong Buchang Pharmaceuticals Plans Joint Investment in Establishing 95%-Owned Subsidiary
Buchang Pharmaceuticals Gets Drug Registration for Blood Sugar, Asthma Medications
Shandong Buchang Pharmaceuticals (603858.SH): Phosphate siglitine tablets and montelukast sodium chewable tablets have obtained the pharmaceutical registration certificates.
On November 21, Gelonghui reported that shandong buchang pharmaceuticals (603858.SH) announced that its wholly-owned subsidiary, shandong danhong pharmaceuticals co., ltd., recently received the "Drug Registration Certificate" approved and issued by the National Medical Products Administration for sitagliptin phosphate tablets and montelukast sodium chewable tablets. Indications for sitagliptin phosphate tablets: 1. Monotherapy. This product, in conjunction with dietary control and exercise, is used to improve blood glucose control in patients with type 2 diabetes. 2. In combination with metformin. When blood glucose control is poor with metformin hydrochloride alone, it can be used in combination with metformin hydrochloride to improve blood glucose control in patients with type 2 diabetes based on diet and exercise.
No Data
No Data